- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04920409
Effect of an Antiinflammatory Diet on Postprandial Gene Expression of Mononuclear Cells of Adult Obese Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A randomized controlled crossover study was conducted. Volunteers underwent to two dietary models for 8 weeks each, including a 2 weeks washout diet between them. The order in which they started the interventions was randomized following a computerized assignment list using Excel software (Microsoft Office 2015, Excel 2013).
The primary endpoint was the postprandial gene expression of nuclear factor kappa B subunit 1 (NFKB1) gene. Based on previous studies , 20 individuals had to be studied to detect a 0.2 difference in the expression of the NKKB1 gene between diets with 0.05 significance level and 80 percentage power (type II error Z 0.2), assuming a 10 percentage drop-out rate.
The recruitment of participants was carried out according to the following steps:
- Review of clinical histories of patients diagnosed with obesity, according to their Body Mass Index, ascribed to the chronic non-communicable diseases program of the Clinica Comfamiliar Risaralda in the city of Pereira Colombia.
- Telephone call to invite the participants who met the inclusion criteria to participate in the study.
- Appointment prior to the start of the study to take a blood sample to corroborate the inclusion criteria. With this sample the following tests were performed: blood glucose, lipid profile, thyroid stimulating hormone (TSH), C-reactive protein ( and complete blood count.
This process was carried out by personnel not involved in the research. The results obtained were compared with the clinical history.
The diets followed during the intervention periods were: (1) a diet consisting mainly of the consumption of fruit, avocado and other vegetables, whole grains and trout typical of the colombian coffee region (FAWGT) (experimental diet), and (2) the usual diet consumed by the participants in their normal lifestyle (UD).
At the beginning of the dietary intervention period, each participant was given an individualized food guide containing the suggested food group and portions, with a wide variety of foods allowed for greater adherence to the diet. In addition, specific times for consumption of the foods and precise instructions for the dietary intervention were given. In addition, the subjects were given a talk advising them how to quantify the portions, which would later be converted into grams according to the procedure described
The food portions were standardized with all the participants using synthetic models, adapted according to the Colombian nutritional guidelines, so that they could provide a more accurate report of the portions consumed during the intervention. In addition, a postprandial studies were carried out at the beginning of the study (pre-intervention) and another after 8 weeks of dietary intervention (post-intervention).
The participants were given an appointment at the health center at 7.00 am, after at least 12 hours of fasting and a 5 day abstinence from alcohol. They consumed a breakfast based on the same composition of the diet in which they were randomized for the dietary intervention period. The blood samples were obtained by veni-puncture at baseline and 4 hours after breakfast. During the postprandial period, the participants did not consume any more food, although they were allowed to drink water. The breakfasts were composed of the following foods: FAWGT diet; whole-grain arepa (with unrefined corn flour), cheese, oats, granadilla, mango, linseed, nuts, almonds, peanuts and yogurt. Usual diet; egg, cheese, butter, whole milk, traditional white arepa (with re-fined corn flour), traditional buñuelo (made from wheat flour with cheese), coffee and sugar.
Before starting the dietary intervention period (Pre-intervention), at the midpoint of the study (week 4) and at the end (week 8), all the participants completed three 24-hour recalls (2 non-consecutive weekdays and one weekend day) to obtain information about food, ingredients and preparations consumed in the same units of measurement (grams).
In addition, a weekly telephone call was made to answer any questions relating to the diet (recipes, menu and quantities) and to motivate adherence to the assigned dietary model.
Moreover, in week four of each intervention, the participants attended the hospital for an interview with the main researcher in order to take anthropometric measurements, evaluate the follow-up of the dietary instructions and answer any questions that may have arisen during the intervention, and motivate them to continue with the study. To collect the information on food consumption, formats and questionnaires previously published by the research group were used.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Risaralda
-
Pereira, Risaralda, Colombia, 16000
- Clínica Comfamiliar Risaralda
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Informed consent
- Body mass index (BMI) ≥ 30 Kg/m^2.
- Clinical: hypertensive and dyslipidemic participants.
Exclusion Criteria:
- Age < 40 or > 65 years
- Patients unable to follow a protocol.
- Psychiatric diseases
- Renal Insufficiency
- Chronic Hepatopathy
- Active Malignancy
- Chronic obstructive pulmonary disease
- Diseases of the digestive tract Endocrine disorders
- Smokers.
- Regular alcohol consumers.
- Participants who were in weight reduction programs
- Prescribed hypolipidaemic medication
- Prescribed anti-inflammatory medication
- Kidney or liver dysfunction.
- Diabetes or other endocrine disorders.
- Chronic inflammatory conditions.
- Patients participating in other Clinical trials (in the enrollment moment or 30 days prior).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FAWGT Diet
Composed of fruit, avocado, whole grains and trout
|
Composed of 15% protein, 55% CH and 30% fat of which < 10% was SFA, 14% MUFA and 6% PUFA in the overall total caloric content.
|
|
Active Comparator: Usual diet (UD)
Based on the food which the participants usually consumed prior to the study in their normal lifestyle.
|
Consisted of 16% protein, 54% carbohydrates (CH) and 30% fat of which 15% was saturated fat (SFA), 10% monounsaturated fat (MUFA) and 5% polyunsaturated fat (PUFA)in relation to the total caloric content
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative expression of the NFKB1 gene
Time Frame: 8 weeks
|
RNA extraction from mononuclear cells, reverse transcription and DNA amplification in fasting and postprandial state.
|
8 weeks
|
|
Relative expression of the Interleukin 6 (IL6) gene
Time Frame: 8 weeks
|
RNA extraction from mononuclear cells, reverse transcription and DNA amplification in fasting and postprandial state.
|
8 weeks
|
|
Relative expression of the tumoral necrosis factor (TNF) gene
Time Frame: 8 weeks
|
RNA extraction from mononuclear cells, reverse transcription and DNA amplification in fasting and postprandial state.
|
8 weeks
|
|
Relative expression of the Interleukin 1 B (IL1B) gene
Time Frame: 8 weeks
|
RNA extraction from mononuclear cells, reverse transcription and DNA amplification in fasting and postprandial state..
|
8 weeks
|
|
Relative expression of the matrix metallopeptidase 9 (MMP)) gene
Time Frame: 8 weeks
|
RNA extraction from mononuclear cells, reverse transcription and DNA amplification in fasting and postprandial state.
|
8 weeks
|
|
Relative expression of the nuclear factor, erythroid 2 like 2 (NFE2L2) gene
Time Frame: 8 weeks
|
RNA extraction from mononuclear cells, reverse transcription and DNA amplification.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline of the gut microbiota
Time Frame: 8 weeks
|
Stool deoxyribonucleic acid (DNA) extraction, library construction, sequencing and bioinformatic analysis.
|
8 weeks
|
|
Change from baseline of DNA methylation pattern
Time Frame: 8 weeks
|
Whole blood DNA extraction and Enzyme-Linked ImmunoSorbent Assay (ELISA)
|
8 weeks
|
|
Triglycerides
Time Frame: 8 weeks
|
Influence of diet on postprandial trygliceride
|
8 weeks
|
|
Insulin
Time Frame: 8 weeks
|
Influence of diet on postprandial insulinemia
|
8 weeks
|
|
Total Cholesterol
Time Frame: 8 weeks
|
Influence of diet on postprandial total Cholesterol
|
8 weeks
|
|
LDL Cholesterol
Time Frame: 8 weeks
|
Influence of diet on postprandial LDL Cholesterol
|
8 weeks
|
|
HDL Cholesterol
Time Frame: 8 weeks
|
Influence of diet on postprandial HDL Cholesterol
|
8 weeks
|
|
VLDL Cholesterol
Time Frame: 8 weeks
|
Influence of diet on postprandial VLDL Cholesterol
|
8 weeks
|
|
C-reactive protein (CRP)
Time Frame: 8 weeks
|
Influence of diet on postprandial CRP
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Clara H Gonzalez Correa, Doctor, Universidad de Caldas
- Principal Investigator: Diana M Muñoz, PhD student, Universidad de Caldas
- Principal Investigator: Oriol A Rangel Zuñiga, Postdoctor, Instituto Maimónides de Investigación Biomédica de Córdoba
- Principal Investigator: Antonio Camargo, Postdoctor, Instituto Maimónides de Investigación Biomédica de Córdoba
- Study Chair: Elcy Y Astudillo Muñoz, Doctor, Universidad Libre
- Study Chair: Gloria L Porras Hurtado, Postdoctor, Clínica Comfamiliar Risaralda
- Study Chair: Maite Sanchez Giraldo, PhD student, Instituto Maimónides de Investigación Biomédica de Córdoba
Publications and helpful links
General Publications
- Hurt RT, Kulisek C, Buchanan LA, McClave SA. The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists. Gastroenterol Hepatol (N Y). 2010 Dec;6(12):780-92.
- Frigolet ME, Dong-Hoon K, Canizales-Quinteros S, Gutiérrez-Aguilar R. Obesity, adipose tissue, and bariatric surgery. Bol Med Hosp Infant Mex. 2020;77(1):3-14. doi: 10.24875/BMHIM.19000115. Review.
- Fernemark H, Jaredsson C, Bunjaku B, Rosenqvist U, Nystrom FH, Guldbrand H. A randomized cross-over trial of the postprandial effects of three different diets in patients with type 2 diabetes. PLoS One. 2013 Nov 27;8(11):e79324. doi: 10.1371/journal.pone.0079324. eCollection 2013.
- Koch W. Dietary Polyphenols-Important Non-Nutrients in the Prevention of Chronic Noncommunicable Diseases. A Systematic Review. Nutrients. 2019 May 9;11(5):1039. doi: 10.3390/nu11051039.
- Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr. 2007 Sep;98(3):458-73. doi: 10.1017/S000711450774268X.
- Perez-Martinez P, Ordovas JM, Garcia-Rios A, Delgado-Lista J, Delgado-Casado N, Cruz-Teno C, Camargo A, Yubero-Serrano EM, Rodriguez F, Perez-Jimenez F, Lopez-Miranda J. Consumption of diets with different type of fat influences triacylglycerols-rich lipoproteins particle number and size during the postprandial state. Nutr Metab Cardiovasc Dis. 2011 Jan;21(1):39-45. doi: 10.1016/j.numecd.2009.07.008. Epub 2009 Oct 9.
- Uusitupa M, Hermansen K, Savolainen MJ, Schwab U, Kolehmainen M, Brader L, Mortensen LS, Cloetens L, Johansson-Persson A, Onning G, Landin-Olsson M, Herzig KH, Hukkanen J, Rosqvist F, Iggman D, Paananen J, Pulkki KJ, Siloaho M, Dragsted L, Barri T, Overvad K, Bach Knudsen KE, Hedemann MS, Arner P, Dahlman I, Borge GI, Baardseth P, Ulven SM, Gunnarsdottir I, Jonsdottir S, Thorsdottir I, Oresic M, Poutanen KS, Riserus U, Akesson B. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome -- a randomized study (SYSDIET). J Intern Med. 2013 Jul;274(1):52-66. doi: 10.1111/joim.12044. Epub 2013 Mar 2.
- Gomez-Marin B, Gomez-Delgado F, Lopez-Moreno J, Alcala-Diaz JF, Jimenez-Lucena R, Torres-Pena JD, Garcia-Rios A, Ortiz-Morales AM, Yubero-Serrano EM, Del Mar Malagon M, Lai CQ, Delgado-Lista J, Ordovas JM, Lopez-Miranda J, Perez-Martinez P. Long-term consumption of a Mediterranean diet improves postprandial lipemia in patients with type 2 diabetes: the Cordioprev randomized trial. Am J Clin Nutr. 2018 Nov 1;108(5):963-970. doi: 10.1093/ajcn/nqy144.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0406716
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on FAWGT diet
-
Laval UniversityDairy Farmers of Canada; Agriculture and Agri-Food CanadaCompleted
-
Medical University of WarsawCompletedDietary Intervention | Metabolic Cardiovascular Syndrome | Vegetarian Diet | Mediterranean Diet | Vegan Diet | Obesity and OverweightPoland
-
Universidad del Centro Educativo LatinoamericanoUniversidad Nacional de RosarioRecruitingNutrition | Cardiovascular (CV) Risk | Cardiometabolic Health IndicatorsArgentina
-
Maastricht University Medical CenterNational Cattlemen's Beef AssociationRecruitingMuscle Protein Synthetic Response to ProteinNetherlands
-
Indiana University School of MedicineNational Institutes of Health (NIH)Completed
-
University of MichiganNot yet recruitingIrritable Bowel SyndromeUnited States
-
Burke Rehabilitation HospitalCompletedStroke | Ischemic StrokeUnited States
-
Tufts Medical CenterCompletedObesity | Cardiovascular Disease | Metabolic Syndrome
-
University of PittsburghCompletedCardiovascular Diseases | ObesityUnited States
-
Kasr El Aini HospitalRecruitingRheumatoid Arthritis (RA)Egypt